vs
CAPITAL CITY BANK GROUP INC（CCBG）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是CAPITAL CITY BANK GROUP INC的1.1倍（$69.8M vs $63.5M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 21.6%，领先362.4%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 6.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 6.0%）
德克萨斯首都银行是一家总部位于得克萨斯州达拉斯的银行，在得克萨斯州所有主要城市均设有网点，其母公司控股公司为得克萨斯首都银行控股集团，同时该机构还运营着纯线上银行部门Bask Bank。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CCBG vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$63.5M
营收增速更快
RIGL
高出15.2%
6.0%
净利率更高
RIGL
高出362.4%
21.6%
两年增速更快
RIGL
近两年复合增速
6.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $63.5M | $69.8M |
| 净利润 | $13.7M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 29.3% | 33.2% |
| 净利率 | 21.6% | 384.0% |
| 营收同比 | 6.0% | 21.2% |
| 净利润同比 | 4.7% | 1769.2% |
| 每股收益（稀释后） | $0.80 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCBGRIGL
| Q4 25 | $63.5M | $69.8M | ||
| Q3 25 | $65.9M | $69.5M | ||
| Q2 25 | $63.2M | $101.7M | ||
| Q1 25 | $61.5M | $53.3M | ||
| Q4 24 | $59.9M | $57.6M | ||
| Q3 24 | $59.7M | $55.3M | ||
| Q2 24 | $58.9M | $36.8M | ||
| Q1 24 | $56.5M | $29.5M |
净利润CCBGRIGL
| Q4 25 | $13.7M | $268.1M | ||
| Q3 25 | $15.9M | $27.9M | ||
| Q2 25 | $15.0M | $59.6M | ||
| Q1 25 | $16.9M | $11.4M | ||
| Q4 24 | $13.1M | $14.3M | ||
| Q3 24 | $13.1M | $12.4M | ||
| Q2 24 | $14.2M | $-1.0M | ||
| Q1 24 | $12.6M | $-8.2M |
毛利率CCBGRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率CCBGRIGL
| Q4 25 | 29.3% | 33.2% | ||
| Q3 25 | 32.0% | 40.9% | ||
| Q2 25 | 31.7% | 60.1% | ||
| Q1 25 | 35.8% | 23.9% | ||
| Q4 24 | 29.0% | 28.9% | ||
| Q3 24 | 26.1% | 25.4% | ||
| Q2 24 | 29.3% | 1.2% | ||
| Q1 24 | 27.2% | -23.6% |
净利率CCBGRIGL
| Q4 25 | 21.6% | 384.0% | ||
| Q3 25 | 24.2% | 40.2% | ||
| Q2 25 | 23.8% | 58.6% | ||
| Q1 25 | 27.4% | 21.5% | ||
| Q4 24 | 21.9% | 24.9% | ||
| Q3 24 | 22.0% | 22.5% | ||
| Q2 24 | 24.0% | -2.8% | ||
| Q1 24 | 22.2% | -27.9% |
每股收益（稀释后）CCBGRIGL
| Q4 25 | $0.80 | $14.11 | ||
| Q3 25 | $0.93 | $1.46 | ||
| Q2 25 | $0.88 | $3.28 | ||
| Q1 25 | $0.99 | $0.63 | ||
| Q4 24 | $0.78 | $0.82 | ||
| Q3 24 | $0.77 | $0.70 | ||
| Q2 24 | $0.83 | $-0.06 | ||
| Q1 24 | $0.74 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $552.9M | $391.5M |
| 总资产 | $4.4B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CCBGRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务CCBGRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CCBGRIGL
| Q4 25 | $552.9M | $391.5M | ||
| Q3 25 | $540.6M | $117.6M | ||
| Q2 25 | $526.4M | $81.9M | ||
| Q1 25 | $512.6M | $18.6M | ||
| Q4 24 | $495.3M | $3.3M | ||
| Q3 24 | $476.5M | $-14.6M | ||
| Q2 24 | $461.0M | $-29.9M | ||
| Q1 24 | $448.3M | $-31.7M |
总资产CCBGRIGL
| Q4 25 | $4.4B | $513.6M | ||
| Q3 25 | $4.3B | $242.5M | ||
| Q2 25 | $4.4B | $206.7M | ||
| Q1 25 | $4.5B | $176.0M | ||
| Q4 24 | $4.3B | $164.0M | ||
| Q3 24 | $4.2B | $139.4M | ||
| Q2 24 | $4.2B | $128.4M | ||
| Q1 24 | $4.3B | $126.5M |
负债/权益比CCBGRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $87.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $80.0M | — |
| 自由现金流率自由现金流/营收 | 126.1% | — |
| 资本支出强度资本支出/营收 | 12.0% | — |
| 现金转化率经营现金流/净利润 | 6.39× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $150.1M | — |
8季度趋势，按日历期对齐
经营现金流CCBGRIGL
| Q4 25 | $87.6M | $22.0M | ||
| Q3 25 | $21.6M | $24.0M | ||
| Q2 25 | $32.6M | $30.5M | ||
| Q1 25 | $21.9M | $-893.0K | ||
| Q4 24 | $63.6M | $14.5M | ||
| Q3 24 | $12.8M | $21.7M | ||
| Q2 24 | $24.9M | $302.0K | ||
| Q1 24 | $14.6M | $-5.0M |
自由现金流CCBGRIGL
| Q4 25 | $80.0M | — | ||
| Q3 25 | $19.8M | — | ||
| Q2 25 | $30.8M | — | ||
| Q1 25 | $19.5M | — | ||
| Q4 24 | $54.9M | — | ||
| Q3 24 | $10.5M | — | ||
| Q2 24 | $23.0M | — | ||
| Q1 24 | $12.4M | — |
自由现金流率CCBGRIGL
| Q4 25 | 126.1% | — | ||
| Q3 25 | 30.1% | — | ||
| Q2 25 | 48.7% | — | ||
| Q1 25 | 31.7% | — | ||
| Q4 24 | 91.7% | — | ||
| Q3 24 | 17.6% | — | ||
| Q2 24 | 39.0% | — | ||
| Q1 24 | 22.0% | — |
资本支出强度CCBGRIGL
| Q4 25 | 12.0% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 3.9% | — | ||
| Q4 24 | 14.5% | — | ||
| Q3 24 | 3.8% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 4.0% | — |
现金转化率CCBGRIGL
| Q4 25 | 6.39× | 0.08× | ||
| Q3 25 | 1.35× | 0.86× | ||
| Q2 25 | 2.17× | 0.51× | ||
| Q1 25 | 1.30× | -0.08× | ||
| Q4 24 | 4.86× | 1.01× | ||
| Q3 24 | 0.97× | 1.75× | ||
| Q2 24 | 1.76× | — | ||
| Q1 24 | 1.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
